A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00429091 · COMPLETED

Trial details

NCT number: NCT00429091
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder ADHD

Start date: 2007-01-01
Primary completion: 2007-08-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.